Skip to main content
West Pharmaceutical Services Inc.
Healthcare · Medical Instruments & Supplies
Made on Sep 3, 2026
Price at call $340.39
6-month call Bear -11.9%
Target by Mar 2027 $300.00
Great value below $210.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change -11.9% to $300.00
Predicted High $342.00 in 2 weeks
Predicted Low $300.00 at 6 months
Max Drawdown (predicted) -11.9%

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Sep 3, 2026 1:09 pm
Bear WST trends lower to $300.00 (-11.9% from $340.39) by Mar 2027. ride-then-fade
ThesisWST trades far above every fair-value anchor with negative value/sentiment scores, but momentum is strong (+37.7% 6mo) and the regime is neutral, so gravity works slowly. Expect a mild near-term drift as the GLP-1 narrative frays, then a stepped decline toward the deterministic baseline as multiple compression bites.
Invalidated ifA decisive break above $360 on GLP-1 platform upside or a beat-and-raise catalyst would falsify the fade thesis.
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $340.39 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Sep 3, 2026 — $340.39 at call — —The anchor — every point below is measured from this price and date.
2 weeks Sep 17, 2026 $323.00–$357.78 typical range · internal point $342.00 — ±5.1% 6/10 low-vol drift, no catalyst, momentum still positive
What actually happened: closed $362.01 on Sep 16, 2026 = +6.4% vs the call (predicted +0.5%)  ·  direction MISS (called flat, was up)  ·  off by 5.9 pp  ·  accuracy 4/10  ·  typical range ±5.1%: OUTSIDE the band  ·  S&P -2.5% over the same window — beat it
1 month Oct 3, 2026 $315.19–$365.59 typical range · internal point $336.50 — ±7.4% 5/10 early narrative fatigue, neutral tape offers no cover
What actually happened: closed $365.00 on Oct 2, 2026 = +7.2% vs the call (predicted -1.1%)  ·  direction MISS (called flat, was up)  ·  off by 8.4 pp  ·  accuracy 4/10  ·  typical range ±7.4%: inside the band  ·  S&P -0.3% over the same window — lagged it
2 months Nov 3, 2026 $328.00 — -3.6% 5/10 valuation gravity begins as anchors reassert
3 months Dec 3, 2026 $318.00 — -6.6% 4/10 year-end positioning trims priced-for-perfection names
4 months Jan 3, 2027 $312.00 — -8.3% 4/10 January reset, quality score modest, sentiment weak
5 months Feb 3, 2027 $305.00 — -10.4% 4/10 pre-earnings de-risking toward baseline endpoint
6 months Mar 3, 2027 $300.00 — -11.9% 4/10 convergence toward deterministic baseline near 297

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $297.06 (-12.7%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

No weaknesses recorded for this run.

All inputs present, no fallbacks used — nothing to flag.

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$340.39
Composite fair value$119.86
Signal-adjusted fair value$123.94
DCF fair value$82.71
Anchored-PE fair value$242.54
Buy-below (value lens)$210.00
Value net score-74
Value confidence6 / 10
Quality net score+21
Memo confidence8 / 10
Deserved value (base)—
Quality tilt—
Deserved value (used)—
Coherence (value × quality)—

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 17.0%  3m 25.6%  6m 31.9%  
Daily σ (realism noise)1.6%
Beta vs S&P 500 1m 0.19  3m 0.28  5m 0.29  
Trailing 6-month return37.7%

Knobs (equation params)

ladder["w2","m1","m2","m3","m4","m5","m6"]
llm_modelclaude-opus-4-7
max_tokens3000
control_knobs{"w_dcf":0.5,"k_qual":0.200000000000000011102230246251565404236316680908203125,"reach_6m":0.450000000000000011102230246251565404236316680908203125,"coh_floor":0.5,"conf_gain":0.059999999999999997779553950749686919152736663818359375,"noise_phi":0.84999999999999997779553950749686919152736663818359375,"conf_floor":0.40000000000000002220446049250313080847263336181640625,"w_composite":0.5,"noise_window":"3m","flat_band_pct":5,"horizon_months":6,"noise_sigma_fallback":0.01499999999999999944488848768742172978818416595458984375}
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Sep 3, 2026 freshest WST-20260903-043001-6b40
ext-forensic-memo Sep 3, 2026 freshest ext-WST-20260903-045513-4cf2
ext-lens-quality Sep 3, 2026 freshest ext-WST-20260903-045513-4cf2
ext-lens-sentiment Sep 3, 2026 freshest ext-WST-20260903-045513-4cf2
ext-lens-value Sep 3, 2026 freshest ext-WST-20260903-045513-4cf2
valuation-synthesis Sep 3, 2026 freshest WST-20260903-043001-6b40

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

1 frozen snapshot — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Sep 3, 2026 v0.6.0 Bear $340.39 $300.00 -11.9% Mar 2027 viewing

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.